Medicine moves
our lives.
Medicine moves our lives.
And serves as a pillar of our society.
In Switzerland, the pharmaceutical industry ensures that patients have access to innovative therapies and modern medicines—often precisely when it matters most.
At the same time, it is a central driver of prosperity and economic strength: it creates value, secures jobs, and contributes significantly to Switzerland’s international competitiveness.
To maintain this, framework conditions are needed that enable innovation, promote investment, and sustainably strengthen Switzerland as a business location.
Medicine moves our lives—
when it matters most.
What does medical innovation mean for our lives?
Access to innovative medicines and therapies is central to effective and modern healthcare.
New treatment options emerge through continuous research, improve quality of life, and create new perspectives—provided they are available in time and supply is secured.
Clinical trials play a key role in this: they enable early access to innovation, drive medical progress forward, and thus give patients more years of life.
benefit from
innovations
Securing access to innovative
therapies.
Availability of medicines.
Innovation and new therapies.
Securing access to innovative
therapies.
Availability of medicines.
Innovation and new therapies.
Medicine moves our lives—
and our future.
Our prosperity is built
on medical innovation.
The pharmaceutical industry is a central pillar of the Swiss economy and one of its most important growth drivers. It creates and secures—directly and indirectly—hundreds of thousands of jobs and makes an above-average contribution to value creation.
As the most significant export sector and one of the strongest economic engines, it contributes decisively to Switzerland’s prosperity and international competitiveness.
The pharmaceutical industry generates CHF 10 billion in tax revenue for Switzerland annually.
Around 300,000 people work in and around the pharmaceutical industry in Switzerland.
The pharmaceutical export sector accounts for over 40% of all Swiss exports with CHF 114 billion.
The pharmaceutical industry generates CHF 10 billion in tax revenue for Switzerland annually.
Around 300,000 people work in and around the pharmaceutical industry in Switzerland.
The pharmaceutical export sector accounts for over 40% of all Swiss exports with CHF 114 billion.
Competition determines where research takes place and where innovations emerge.
Framework conditions for research and innovation are changing worldwide. Many countries are deliberately creating attractive conditions to attract pharmaceutical companies and promote investment.
Competition for capital, talent, and innovation is increasing. Switzerland is also part of this competition—and must actively secure its position.
What is still strong today is increasingly coming under pressure.
Framework conditions determine where investments are made
Pharmaceutical companies are increasingly investing abroad
Attractive locations attract new investments
Downloads
for download